Optimal Value Increase of Egg Products (OPTIEgg)

University of Oslo

Status: Completed

Conditions: Aging; Inflammation; Healthy

Treatments: Other: Placebo; Other: Eggshell membrane (ESM)

Study type: Interventional

Funder types: Other

Identifiers

NCT04606628

2020/95084/REK Sør-Øst

Details and patient eligibility

About

The aim of this project is to evaluate daily intake of eggshell membrane taken as supplement (capsule), will reduce markers of inflammation in older people.

Enrollment: 57 patients

Sex: All

Ages: 70 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

The study will include home-dwelling men and women ≥ 70 years. All subjects have to be in a good enough condition to meet up at the Department of Nutrition, University of Oslo at two occasions during the study period.

Exclusion criteria

• CRP >10 mg/L
• Egg allergy
• Use of medication affecting inflammation
• Unstable use of medication or supplements last 3 months
• Unwilling to keep the physical activity level, habitual dietary intake, tobacco use and weight stable during the study period
• Severe illness last 3 months
• Unwilling to perform physical tests
• Eligibility
• Diabetes type I or II, HbA1c ≥ 6.5 %

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

57 participants in 2 patient groups

Intervention

Experimental group

Description:

Participants will consume 2 capsules containing eggshell membrane(ESM) with breakfast every day in 4 weeks.

Treatment:

Other: Eggshell membrane (ESM)

Placebo

Experimental group

Description:

Participants will consume 2 capsules with no bioactive substance (placebo) with breakfast every day in 4 weeks.

Treatment:

Other: Placebo